Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunology: Oral solutions.

× No keyword cloud information.

10 in total

1. Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice.

Authors: Dheeraj Verma; Babak Moghimi; Paul A LoDuca; Harminder D Singh; Brad E Hoffman; Roland W Herzog; Henry Daniell
Journal: Proc Natl Acad Sci U S A Date: 2010-03-29 Impact factor: 11.205

2. Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants.

Authors: P Quade-Lyssy; P Milanov; D Abriss; C Ungerer; C Königs; E Seifried; J Schüttrumpf
Journal: J Thromb Haemost Date: 2014-06 Impact factor: 5.824

3. Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cells.

Authors: Xiaomei Wang; Babak Moghimi; Irene Zolotukhin; Laurence M Morel; Ou Cao; Roland W Herzog
Journal: Mol Ther Date: 2014-03-10 Impact factor: 11.454

4. Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain.

Authors: F E Rawle; K P Pratt; A Labelle; H L Weiner; C Hough; D Lillicrap
Journal: J Thromb Haemost Date: 2006-07-05 Impact factor: 5.824

Review 5. The gene therapy journey for hemophilia: are we there yet?

Authors: Katherine A High
Journal: Blood Date: 2012-07-24 Impact factor: 22.113

6. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins.

Authors: Tie Chi Lei; David W Scott
Journal: Blood Date: 2005-03-15 Impact factor: 22.113

7. Repeated oral administration of chitosan/DNA nanoparticles delivers functional FVIII with the absence of antibodies in hemophilia A mice.

Authors: S S Dhadwar; J Kiernan; J Wen; G Hortelano
Journal: J Thromb Haemost Date: 2010-12 Impact factor: 5.824

8. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice.

Authors: Tracey Ruhlman; Raheleh Ahangari; Andrew Devine; Mohtahsem Samsam; Henry Daniell
Journal: Plant Biotechnol J Date: 2007-05-09 Impact factor: 9.803

9. Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles.

Authors: Katherine Bowman; Rita Sarkar; Sanj Raut; Kam W Leong
Journal: J Control Release Date: 2008-06-27 Impact factor: 9.776

10. Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.

Authors: Alexandra Sherman; Jin Su; Shina Lin; Xiaomei Wang; Roland W Herzog; Henry Daniell
Journal: Blood Date: 2014-05-13 Impact factor: 22.113

10 in total

3 in total

1. Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.

Authors: Jin Su; Alexandra Sherman; Phillip A Doerfler; Barry J Byrne; Roland W Herzog; Henry Daniell
Journal: Plant Biotechnol J Date: 2015-06-05 Impact factor: 9.803

2. Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.

Authors: Jin Su; Liqing Zhu; Alexandra Sherman; Xiaomei Wang; Shina Lin; Aditya Kamesh; Joey H Norikane; Stephen J Streatfield; Roland W Herzog; Henry Daniell
Journal: Biomaterials Date: 2015-08-05 Impact factor: 12.479

3. Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce.

Authors: Roland W Herzog; Timothy C Nichols; Jin Su; Bei Zhang; Alexandra Sherman; Elizabeth P Merricks; Robin Raymer; George Q Perrin; Mattias Häger; Bo Wiinberg; Henry Daniell
Journal: Mol Ther Date: 2017-02-01 Impact factor: 11.454

3 in total